Bienvenidos a esta plataforma de apoyo para la serie Covid20. Puedes acceder desde aquí a la bibliografía con enlaces directos y a la página fe de errores de la primera edición, así como a la mayoría de los enlaces referenciados en los artículos del volumen I.
Si buscas o necesitas acceso a algún enlace que aún no esté disponible aquí, escríbenos por favor a info@cauac.es
Covid20 - Volúmen I
Lista de enlaces por temáticas
1. Pruebas PCR
2. Pruebas de anticuerpos y antígenos
3. Sindemia
4. Covid-19 como síndrome inflamatorio
5. Causalidad vírica en evidencia
6. Contaminación electromagnética, metales pesados y gases tóxicos
7. Vacunación y sobremedicalización
8. Protocolos iatrogénicos.
9. Sesgo y fraude en las cifras oficiales
Bibliografía
ABBOTT, 2020. “PANBIO COVID-19 AG Rapid Test Device”. Ficha técnica. Enlace.
ALMEIDA, J.D. TYRRELL, D.A. 1967. “The Morphology of Three Previously Uncharacterized Human Respiratory Viruses that Grow in Organ Culture”. Journal of General Virology, 1(2): 175-178. Doi: 10.1099/0022-1317-1-2-175. Enlace.
ALWIS, R. CHEN, S. et al. 2020. “Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development”. EbioMedicine 55: 102768. Doi: 10.1016/j.ebiom.2020.102768. Enlace.
ANDREWES, C.L. 1949. “The natural history of the common cold” The Lancet, 8; 1(6541): 71-75. Doi: 10.1016/s0140-6736(49)90398-0. Enlace.
ARNOLD, W. HUTH, F. 1979. “Viruses, virus-like and virus-related structures in nasopharyngeal carcinoma”. Archives of Oto-rhino-laryngology 222(4): 295-317. Doi: 10.1007/bf01261176. Enlace.
ARON-MAOR, A. SHOENFELD, Y. 2001. “Vaccination and systemic lupus erythematosus: the bidirectional dilemmas”. Lupus 10(3): 237-40. Doi: 10.1191/096120301673085478. Enlace.
ASTIGARRAGA, I. GONZALEZ-GRANADO, L.I. et al. 2018. “Síndromes hemofagocíticos: La importancia del diagnóstico y tratamiento precoces.” Anales de Pediatría 89(2): 124.e1-124.e8. Doi: 10.1016/j.anpedi.2018.05.003. Enlace.
AZZOUZ, D. PALANIYAR, N. 2018. “ApoNETosis: discovery of a novel form of neutrophil death with concomitant apoptosis and NETosis”. Cell Death and Disease 9: 839. Doi.org/10.1038/s41419-018-0846-9. Enlace.
BACHRACH, U. FRIEDMANN, A. 1971. “Practical Procedures for the Purification of Bacterial Viruses”. Applied Microbiology 22(4): 706-715. Doi:10.1128/am.22.4.706-715.1971. Enlace.
BALAKUMAR, P. ROHILLA, A. THANGATHIRUPATHI, A. 2010. “Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?” Pharmacological Research 62:(3): 179-186. Doi: 10.1016/j.phrs.2010.04.004. Enlace.
BALMORI, A. 2010. “Mobile phone mast effects on common frog (Rana temporaria) taspoles. Electriagnetic Biology and Medicine 1-2:31-35. Doi: 10.3109/15368371003685363. Enlace.
BALMORI A, HALLBERG Ö. 2007. “The urban decline of the house sparrow (Passer domesticus): a possible link with electromagnetic radiation”. Electromagnetic Biology and Medicine, 26(2): 141-51. Doi:10.1080/15368370701410558. Enlace.
BALMORI, A. 2006b. “Efectos de las radiaciones electromagnéticas de la telefonía móvil sobre los insectos”. Ecosistemas 15(1): 87-95. Enlace.
BAO, L. DENG, W. et al. 2020. “The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice”. Nature 583 (7818): 830-833. Doi: 10.1038/s41586-020-2312-y. Enlace.
BASTARD, P. ROSEN, L. et al. “Autoantibodies against type I IFNs in patients with life-threatening COVID-19”. Science 370. Doi:10.1126/science.abd4585. Enlace.
BECKER, R.O. SELDON, G. 1985. The body electric. William Morrow and Company (HarperCollins) Publishers, New York, EEUU. Enlace.
BELOUSSOV, L.V. OPITZ, J.M. GILBERT, S.F. 2004. “Life of Alexander G. Gurwitsch and his relevant contribution to the theory of morphogenetic fields”. International Journal of Developmental Biology 41(6): 771-777. Enlace.
BENACH, J.L. BOSLER, E.M. et al. 1983. “Spirochetes isolated from the blood of two patients with Lyme disease”. The New England Journal of Medicine, 308 (13): 740-742. Doi: 10.1056/NEJM198303313081302. Enlace.
BEN-SHMUEL, A. BROSH-NISSIMOV, T. et al. 2020. “Detection and infectivity potential of sever acute respiratory syndrome coronavirus 2 (SARS-CoV2) environmental contamination in isolation units and quarantine facilities”. Clinical Microbiology and infection 26(12):1658-1662. Doi: 10.1016/j.cmi.2020.09.004 Enlace.
BJØRNSKOV, C. 2021. “Did Lockdown Work? An Economist’s Cross-Country Comparison”. CESifo Economic Studies ifab0003. Doi: 10.1093/cesifo/ifab003. Enlace.
BLANCK, M. GOODMAN, R. 2011. “DNA is a fractal antenna in electromagnetic fields”. International journal of Radiation Biology 87(4): 409-415. Doi: 10.3109/09553002.2011.538130. Enlace.
BLINOV, V.M. ZVEREVA, V.V. et al. 2017. “Viral component of the human genome” Molecular Biology 51 (2): 205-215. Doi:10.1134/S0026893317020066. Enlace.
BOLLES, M. DEMING, D. et al. 2011.“A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.” Journal of Virology 85(23): 12201-15. Doi: 10.1128/JVI.06048-11. Enlace.
BORGER, P. MALHOTRA, B.R. et al. 2020. Corman–Drosten review report. Enlace.
BOSCH, B.J. VAN DER ZEE, R. et al 2003. “The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex”. Journal of Virology 77(16): 8801-8811. Doi: 10.1128/JVI.77.16.8801–8811.2003. Enlace.
BOUILLON, R. SCHUIT, F. et al. 2020. “Vitamin D Binding Protein: A Historic Overview” Frontiers in Endocrinology (Lausanne) 10(10): 910. Doi: 10.3389/fendo.2019.00910. Enlace.
BRADBURNE, A. F., BYNOE, M. L. TYRRELL, D.A. 1967. “Effects of a “New” Human Respiratory Virus in Volunteers” British Medical Journal 3(5568): 767-769. Doi: 10.1136/bmj.3.5568.767. Enlace.
BRENETTA, J. CREENSHAW. B.J. et al. 2019. “Alcohol Modulates Biogenesis and Composition of Microglia-Derived Exosomes”. Biology (Basel) 8(2): 25. Doi: 10.3390/biology8020025. Enlace.
BRUNO, R. 2020. “Las vacunas covid-19 podrían afectar la fertilidad” CienciaySaludNatural.com. Enlace.
BUCHAN, I. 2020. Liverpool Covid 19 Community Testing Pilot. Interim Evaluation Report. Universidad de Liverpool, Informe interno, Enlace.
BULLARD, J. DUST, K. et al. 2020. “Predicting infectious SARS-CoV2 from diagnostic samples”. Clinical infectious diseases 17; 71(10):2663-2666. Doi: 10.1093/cid/ciaa638. Enlace.
BURR, H.S. 1972. Blueprint for immortality: the electric patterns of life. Neville Spearman Publishers, London. Enlace.
BUSTIN, S. BENES, V. et al. 2009. “The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments”. Clinical Chemistry 55(4): 611-22. Doi: 10.1373/clinchem.2008.112797. Enlace.
BUSTIN, S. NOLAN, T. 2020. “RT-qPCR Testing of SARS-CoV-2: A Primer” International Journal of Molecular Sciences 21(8): 3004. Doi: 10.1373/clinchem.2008.112797. Enlace.
CALDERÓN-GARCIDUEÑAS, L. MACÍAS-PARRA, M. et al. 2009. “Immunotoxicity and environment: immunodysregulation and systemic inflammation in children”. Toxicologic Pathology 37(2): 161-169. Doi: 10.1177/0192623308329340. Enlace.
CAO, S. GAN, Y. et al. 2020. “Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China”. Nature communications 11: 5917. Doi: 10.1038/s41467-020-19802-w. Enlace.
CARR. S.M. GRIFFITHS, O.M. 1987. “Preparative density-gradient ultracentrifugation of DNA” Biochemical Genetics 25:385-390. Enlace.
CARSANA, L. SONZOGNI, A. et al. 2020. “Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy”. MedRxiv Preprint. Doi:10.1101/2020.04.19.20054262. Enlace.
CDC 2020a. CDC 2019-Novel Coronavirus (2019-nCoV), Real-Time RT_PCR diagnostic Panel. For Emergency Use Only. Instructions for Use. Center for Disease Control and Prevention Atlanta, EEUU. Enlace.
CDC 2020b. Preparation of viral transport medium Center for Disease Control and Prevention Publishers, Atlanta. EEUU. Enlace.
CHAN, J.F., ZHANG, A.J. et al. 2020. “Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility”. Clinical Infectious Diseases 71 (9): 2428-2446. Doi: 10.1093/cid/ciaa325. Enlace.
CHATERJEE, B. KARANDIKAR, R.L. et al. 2021. “Mortality due to COVID-19 in different countries is associated with their demographic character and prevalence of autoimmunity”. Current Science 120(3): 501-508. Doi: 10.18520/cs/v120/i3/501-508. Enlace.
CHAUDRY, R. et al. 2020. “A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes”. EclinicalMedicine 25(2020): 100464. Doi: 10.1016/j.eclinm.2020.100464. Enlace.
CHIESA, M. HERNANDEZ, S. 2020. “PCR positives: what do they mean?”. The Centre for Evidence-Based Medicine. Enlace.
CHIN, J. MAGOFFIN, R.L. et al. 1969. “Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.” American Journal of Epidemiology 89(4): 449-463. Doi: 10.1093/oxfordjournals.aje.a120957. Enlace.
CHUONG, E.B. ELDE, N.C. FESCHOTTE, C. 2016. “Regulatory evolution of innate immunity through co-option of endogenous retroviruses.” Science 351(6277):1083-7. Doi: 10.1126/science.aad5497. Enlace.
CIFRA, M. FIELDS, J. Z. FARHADI, A. 2011. “Electromagnetic cellular interactions”. Progress in Biophysics and Molecular Biology 105(3): 223-246. Doi: 10.1016/j.pbiomolbio.2010.07.003. Enlace.
COHEN, S. POPP, F. A. 2003. Biophoton emission of human body. Indian Journal of Experimental Biology 41(5): 440-5. Doi:10.1016/S1011-1344(97)00050-X. Enlace.
COLANERI, M. SEMINARI, E. et al. 2020. “Severe acute respiratory syndrome coronavirus 2 RNA cotamination of inanimate surfaces and virus viability in a health care emergency unit”. Clinical Microbiology and infection 26:1094e1-1094e5. Doi: 10.1016/j.cmi.2020.05.009. Enlace.
COMUNIAN, S. DONGO, D. et al. 2020. “Air pollution and COVID-19: the role of particulate matter in the spread and increase of COVID-19’s morbidity and mortality”. International Journal of Environmental Research and Public Health 17(12): 4487. Doi: 10.390/ijerph17124487. Enlace.
CORBELLA, J. 2004 Esquemes de Toxicologia Industrial (I). Introducció – Metals. Publicacions del Seminari Pere Mata 92, Universidad de Barcelona, España. Enlace.
CORMAN, V.M. DROSTEN, C. et al. 2020. “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR”. Eurosurveillance 25 (3): 2000045. Doi: 10.2807/1560-7917.ES.2020.25.3.2000045. Enlace.
COWAN, T.S. FALLON, S. 2020. The Contagion Myth. Simon and Schuster Publishers, New York, EEUU. Enlace.
CREATIVE DIAGNOSTICS, 2020. kit RT-qPCR. Ficha técnica. Enlace.
DEL GIUDICE, E. TEDESCHI, A. et al. 2013. “Coherent structures in liquid water close to hydrophilic surfaces”. Journal of Physics: Conference Series 442(1): 012028. Doi: 10.1088/1742-6596/442/1/012028. Enlace.
DEMING, D. SHEAHAN, T. et al. 2006. “Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.” PLoS Medicine 3 (12): e525. Doi: 10.1371/journal.pmed.0030525. Enlace.
DICKS, M. SPENCER, A.J. et al. 2012. “A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity” PLoS One 7(7): e40385. Doi:10.1371/journal.pone.0040385. Enlace.
DITTMAYER, C. MEINHARDT, J. et al. 2020. “Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral”. The Lancet 396 (10260): e64-e65. Doi: 10.1016/S0140-6736(20)32079-1. Enlace.
DOYON P. 2020. “China, 5G, and the Wuhan Coronavirus: the emperor’s new virus”. ElectricSense. Enlace.
DUNLAP, K.A. PALMARINI, M. et al. 2006. “Endogenous retroviruses regulate periimplantation placental growth and differentiation” Proceedings of the National Academy of Sciences of the United States of America, 103 (39): 14390-14395. Doi: 10.1073/pnas.0603836103. Enlace.
EBMPHET CONSORTIUM. 2020. COVID-19 Severity in Europe and the USA: Could the Seasonal Influenza Vaccination Play a Role? SSRN (Elsevier) Publishers, Berkeley, California, EEUU. Doi: 10.2139/ssrn.3621446. Enlace.
ENGELBRECHT, T. DEMETER, K. 2020. Covid 19 Tests are Scientifically Meaningless. OffGuardian Publishers, EEUU, Reino Unido. Enlace.
ETXEBARRIA, J.A. 2020. Reflexiones del decano del colegio de Biólogos de Euskadi sobre las medidas adoptadas en la crisis de la covid-19. Médicos por la verdad, España. Enlace.
ETXEBARRIA, J.A. 2021. “Utilización de los test PCR, porcentaje de positivos e Incidencia Acumulada a 14 días” Biologos por la Verdad, España. Enlace.
FELDMAN, Y. PUZENKO, A. et al. 2008. “Human skin as arrays of helical antennas in the millimeter and submillimeter wave range”. Physics Review Letters 28, 100(12): 128102. Doi: 10.1103/PhysRevLett.100.128102. Enlace.
FESENKO, E.E. MAKAR, V.R. et al. 1999. “Microwaves and cellular immunity: I. Effect of whole body microwave irradiation on tumor necrosis factor production in mouse cells.” Bioelectrochemistry and Bioenergetics 49(1):29-35. Doi: 10.1016/s0302-4598(99)00058-6. Enlace.
FIRSTENBERG, A. 2017. The invisible rainbow: a history of electricity and life. AGB Publishers. Santa Fé, New Mexico, EEUU. Enlace.
FOUCHIER, R.A. KUIKEN, T. et al. 2003. “Koch’s postulates fulfilled for SARS virus”. Nature 423 (6937): 240. Doi: 10.1038/423240a. Enlace.
FRANCESCO, N. 2020. “Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?” Swiss Medical Weekly 150: w20249. Doi: 10.4414/smw.2020.20249. Enlace.
FUKAYA, S. YASUDA, S. et al. 2008. “Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases”. Rheumatology 47 (11): 1686-1691. Doi: 10.1093/rheumatology/ken342. Enlace.
FULGINITI, V.A., ELLER, J.J. et al. 1969. “Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.” American Journal of Epidemiology, 89(4):435-48. Doi: 10.1093/oxfordjournals.aje.a120956. Enlace.
GALLAHER, B. 2020. “Response to nCoV2019 against backdrop of endogenous retroviruses”. NCoV2019 Evolutionary History. Enlace.
GAO, M. YANG, L. et al. 2020. “A study on infectivity of asymptomatic SARS-CoV-2 carriers” Respiratory Medicine 169: 106026. Doi: 10.1016/j.rmed.2020.106026. Enlace.
GARCÍA ONTORIA-OVIEDO, I. et al. 2015. “Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells”. PLoS One 10(9): e0138849. Doi: 10.1371/journal.pone.0138849. Enlace.
GARCÍA ARRIBAS, O. 2004. Efectos biológicos de campos magnéticos de muy baja frecuencia y radiofrecuencia en presencia de metales pesados: cadmio y mercurio. Tesis sin publicar, Universidad Complutense de Madrid, España. Enlace.
GARCÍA BLANCA, J. 2020. “La estafa se constata. La PCR no detecta el SARS Cov2”. Discovery salud 242. Enlace.
GASTÓN J.F. 2020. Posible interferencia inmunológica entre el Polisorbato 80 de la vacuna antigripal adyuvada y el Sars-CoV-2 como causa de la pandemia por coronavirus. Informe interno, sin publicar. Enlace.
GATTI, A.M. MONTANARI, S. 2017. “New Quality-Control Investigations on Vaccines: Micro- and Nanocontamination”. International Journal of Vaccines and Vaccination 4(1): 00072. Doi: 10.15406/ijvv.2017.04.00072. Enlace.
GEORGET, M. 2017. Vaccinations. Les vérités Indésirables – S’informer, Choisir, Assumer. Dangles Publishers, Toulose, Francia. Enlace.
GIANNESSI, F. AIELLO, A. et al. 2020. “The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses”. Viruses 12 (5): 571. Doi:10.3390/v12050571. Enlace.
GOLDBERG, B.S. ACKERMAN M.E. 2020.“Antibody-mediated complement activation in pathology and protection.” Immunology and Cell Biology 98 (2020): 305-317. Doi: 10.1111/imcb.12324. Enlace.
GOTZSCHE, P.C. 2020. Medicamentos que matan y crimen organizado – 8ªed.: Cómo las grandes farmacéuticas han corrompido el sistema de salud. Lince Editorial, Barcelona, España. Enlace.
GOULD, S.J. 1999. La vida maravillosa. Crítica Editorial, Barcelona, España. Enlace.
GRIMALDI, S. PASQUALI, E. et al. 1997. “Exposure to a 50 Hz electromagnetic field induces activation of the Epstein-Barr virus genome in latently infected human lymphoid cells”. Journal of Environmental Pathology, Toxicology, and Oncology 16(2-3):205-7. PMID: 9276003. Enlace.
GUIMARAES, L.E. BAKER, B. et al. 2015: “Vaccines, adjuvants and autoimmunity”. Pharmacological Research 100:190-209. Doi: 10.1016/j.phrs.2015.08.003. Enlace.
HADHAZY, A. 2010. “Think Twice: How the Gut’s “Second Brain” Influences Mood and Well-Being”. Scientific Amercian. Enlace.
HAKIM, N.N. CHI, J. et al. 2020. “Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients” Experimental Biology and Medicine 246(1): 5-9. Doi: 10.1177/1535370220962043. Enlace.
HALSTEAD, S.B., O’ROURKE, E.J. 1977. “Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.” Journal of Experimental Medicine, 1; 146(1): 201-217. Doi: 10.1084/jem.146.1.201. Enlace.
HAMER, R.D. 1997. El testamento de una nueva medicina (PDF). Manuscrito sin publicar. Enlace.
HAMRE, D. J PROCKNOW J.J. 1966. “A New Virus Isolated from the Human Respiratory Tract”. Proceedings of the Society for Experimental Biology and Medicine 121(1): 190-193. Doi: 10.3181/00379727-121-30734. Enlace.
HARCOURT, J. TAMIN, A. et al. 2020. “Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States” Emerging Infectious Diseases 26(6): 1266-1273. Doi: 10.3201/eid2606.200516. Enlace.
HARDELL, L. CARLBERG, M. GEE, D. 2013. “Mobile phone use and brain tumour risk: early warnings, early actions?” En: Late lessons from early warnings: science, precaution, innovation, capítulo 21: 509-530. European Environmental Agency Publishers. Copenhagen. Enlace.
HAYDEN, A., PARK, S. et al. 2016. “Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review”. Blood Review 30: 411-420. Doi: 10.1016/j.blre.2016.05.001. Enlace.
HENTER, J.I. HORNE, A. et al. 2007. HLH‐2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood Cancer 48: 124–31. Doi: 10.1002/pbc.21039. Enlace.
HIKMET, F. MEAR, L. et al. 2020. “The protein expression profile of ACE2 in human tissues”. Molecular Systems Biology 16(7): e9610. Doi: 10.15252/msb.20209610. Enlace.
HO, M.W. 2008. The rainbow and the worm: the physics of organisms. World Scientific Publishers, Singapore. Enlace.
HO, M.S., CHEN, W.J. et al. 2005. “Neutralizing antibody response and SARS severity.” Emerging Infectious Diseases, 11(11): 1730-1737. Doi: 10.3201/eid1111.040659. Enlace.
HOFMANN, H. PYRC, K. et al 2005. “Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry”. Proceedings of the Natural Academy of Sciences 102(22): 7988-93. Doi: 10.1073/pnas.0409465102. Enlace.
HOME VACCINE EDUCATIONAL HOMEWORK, 2020. “The influenza vaccine and COVID-19”. homevaccineeducationalnetwork.com. Enlace.
IANKOV, I.D., PANDEY, M. et al. 2006 “Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.” Journal of Virology, 80(17): 8530–8540. Doi: 10.1128/JVI.00593-06. Enlace.
IGLÓI, Z. IEVEN, M. et al. 2020. “Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2”. Journal of Clinical Virology 129: 104510. Doi: 10.1016/j.jcv.2020.104510. Enlace.
IKÄHEIMO, T.I. JAAKKOLA, K. et al. 2016. “A Decrease in Temperature and Humidity Precedes Human Rhinovirus Infections in a Cold Climate”. Viruses, 8 (9): 244. Doi: 10.3390/v8090244. Enlace.
IOANIDIS, J.P. 2020. “The infection fatality rate of COVID-19 inferred from seroprevalence data”. Bulletin of the World Health Organization 99: 19–33F. Doi: 10.2471/BLT.20.265892. Enlace.
JACOBSON, J. I. 2016. “A quantum theory of disease, including cancer and aging”. Integrative Molecular Medicine 3(1): 524-541. Doi: 10.15761/IMM.1000200. Enlace.
JEFFERSON, T, HENEGHAN C. et al 2020a. “Are you infectious if you have a positive PCR test result for COVID-19?” The Centre for Evidence-Based Medicine. Enlace.
JEFFERSON, T, HENEGHAN C. et al. 2020b. “Viral cultures for COVID-19 infectivity assessment – a systematic review”. Clinical Infectious Diseases ciaa1764. Doi: 10.1093/cid/ciaa1764. Enlace.
JONES, T. MÜLEMANN, B. et al. 2021 “An analysis of SARS-CoV-2 viral load by patient age”. Science eabi5273. Doi: 10.1126/science.abi5273. Enlace.
JONSDOTTIR, H.R. DIJKMAN, R. 2016. “Coronaviruses and the human airway: a universal system for virus-host interaction studies”. Virology Journal 13: 24. Doi: 10.1186/s12985-016-0479-5. Enlace.
KAPIKIAN, A.Z. MITCHELL, R.H. et al. 1969. “An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.” American Journal of Epidemiology 89 (4): 405-421. Doi: 10.1093/oxfordjournals.aje.a120954. Enlace.
KAUFMANN, J. NETTELBECK, D. 2012. “Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond” Trends in Molecular Medicine 18 (7): 365-376. Doi: 10.1016/j.molmed.2012.04.008. Enlace.
KHAN A.A. KHAN Z. 2020. “COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak”. Bioinformatics 36(13): 4065-4069. Doi: 10.1093/bioinformatics/btaa285. Enlace.
KHURANA, S. LOVING, C.L. et al. 2013 “Vaccine-Induced Anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease”. Science Translational Medicine 5:200ra114. Doi: 10.1126/scitranslmed.3006366. Enlace.
KIM, H.W. CANCHOLA, J.G. et al. 1969. “Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine”. American Journal of Epidemiology, 89 (4): 422-434. Doi: 10.1093/oxfordjournals.aje.a120955. Enlace.
KLEIN, S. CORTESE, M. et al. 2020. “SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography”. Nature Communications 11: 5885. Doi: 10.1038/s41467-020-19619-7. Enlace.
KILLINGTONG, R.A. STOKES, A. HIERHOLZER, J.C. 1996. “Virus purification”. En Virology Methods Manual pp 71-89. Academic Press Publishers. Cambridge, Massachusetts. Doi: 10.1016/B978-012465330-6/50005-1. Enlace.
KLINGHARDT, D. 2017. EMF and the Potentiation of Pathogens and Heavy Metals: Effective Mitigation and Detox. Presentación sin publicar. Klinghard Institute, Glottertal, Alemania. Enlace.
KONNO, Y. KIMURA, I. et al. 2020. “Sars-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant.” Cell reports, 32 (12): 108185. Doi: 10.1016/j.celrep.2020.108185. Enlace.
KOONIN, E.V. 2010. “The wonder world of microbial viruses”. Expert Review of Anti-Infective Therapy 8(10): 1097–1099. Doi: 10.1586/eri.10.96. Enlace.
KORSMAN, S.J. VAN ZYL, G.U. et al. 2012. “Human coronaviruses”. Virology 2012: 94-95. Doi: 10.1016/B978-0-443-07367-0.00040-9. Enlace.
KUMAR, A. KODIDELA, S. et al. 2020. “Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention”. Viruses 12(8): 887. Doi: 10.3390/v12080887. Enlace.
LALONDE, M. 1981. A new perspective on the health of Canadians. Minister of Supply and Services, Government of Canada. Informe Interno. Enlace.
LAMARCK, J.B. 2017. Filosofía zoológica. La Oveja Roja Publishers, Madrid. (Ed. Original 1809). Enlace.
LANKA, S. 2016 OLG Stuttgart Urteil vom 16.2.2016, 12 U 63/15″[OLG Stuttgart judgment of 16 February 2016, 12 U 63/15]. lrbw.juris.de. Enlace.
LAUE, M. KAUTER, A. et al. 2021. “Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin sections of infected Vero cell cultures” Scientific Reports 11: 3515. Doi: 10.1038/s41598-021-82852-7. Enlace.
LECUIT, M. ELOIT, M. 2013. “The human virome: new tools and concepts” Trends in Microbiology 21 (10): 510-515. Doi: 10.1016/j.tim.2013.07.001. Enlace.
LEE, G.I., SARAVIA, J. et al. 2014 “Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection”. Particle and Fibre Toxicology 11: 57. Doi:10.1186/s12989-014-0057-1. Enlace.
LEE, T.X. 2020. “Covid-19 Heavy Metal Hypothesis”. Qeios Preprint. Doi: 10.32388// OF0L6S.3. Enlace.
LEE, W.S., WHEATLEY, A.K. et al. 2020. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nature Microbiology 5: 1185–1191. Doi: 10.1038/s41564-020-00789-5. Enlace.
LEVIN, M. 2003. “Bioelectromagnetics in morphogenesis”. Bioelectromagnetics 24(5): 295-315. Doi: 10.1002/bem.10104. Enlace.
LIBOFF, A. R. 2004. Towards an electromagnetic paradigm for biology and medicine. The Journal of Alternative & Complementary Medicine 10(1): 41-47. Doi: 10.1089/107555304322848940. Enlace.
LINDSTRÖM, B. ERIKSSON, M. 2005. “Salutogenesis”. Journal of Epidemiology & Community Health, 59: 440-442. Doi: 10.1136/jech.2005.034777. Enlace.
LIU, L. WEI, Q. et al. 2019. “Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.”Journal of Clinical Investigation Insight 4 (4): e123158. Doi: 10.1172/jci.insight.123158. Enlace.
MAHLER, H.R. PERLMAN, P.S. 1972. “Effects of mutagenic treatment by ethidium bromide on cellular and mitochondrial phenotype” Archives of Biochemistry and Biophysics 148(1):115-29. Doi: 10.1016/0003-9861(72)90122-1. Enlace.
MAK, A. TAY, S.H. 2012. “Environmental Factors, Toxicants and Systemic Lupus Erythematosus”. International Journal of Molecular Sciences 15(9): 16043–16056. Doi: 10.3390/ijms150916043. Enlace.
MAKARY, M.A. DANIEL, M. 2016. “Medical error – the third leading cause of death in the US”. The British Medical Journal 353: i2139. Doi: 10.1136/bmj.i2139. Enlace.
MARTÍNEZ ALBARRACÍN, M.J 2020a. “Estudio de las pruebas analíticas para la detección del SARS-Cov2”. Dossier Cv20, Cauac Editorial, Murcia, España.
MARTÍNEZ ALBARRACÍN, M.J. 2020b. “La covid-19 es un síndrome de inmunodeficiencia mediada por tóxicos y/o por vacunas”. Dossier Cv20, Cauac Editorial, Murcia, España.
MAXMEN, A. 2010. “The gut’s ‘friendly’ viruses revealed”. Nature. Doi: 10.1038/news.2010.353. Enlace.
McINTOSH, K. DEES, J.H. et al. 1967. “Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease by laboratory of infectious diseases”. Proceedings of the National Academy of Science of the United States of America 57(4): 933-940. Doi: 10.1073/pnas.57.4.933. Enlace.
MENENDEZ, C. 2020. “Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19”. Aging 12: 8760-8765. Doi: 10.18632/aging.103347. Enlace.
MEHTA P, MCAULEY D.F. et al. 2020. “COVID-19: consider cytokine storm syndromes and immunosuppression”. Lancet 395(10229): 1033-1034. Doi: 10.1016/S0140-6736(20)30628-0. Enlace.
MEUNIER, T. 2020. “Full lockdown policies in Western Europe countries have no evident impacts on the COVID-19 epidemic”. MedRxiv, preprint 01-05-2020. Doi: 10.1101/2020.04.24.20078717. Enlace.
MIKOVITS, J. HECKENLIVELY, K. 2020. Plaga de corrupción científica. La Tempestad Editorial, Barcelona, España.
MILLER, S.E. GOLDSMITH, C.S. 2020. “Caution in Identifying Coronaviruses by Electron Microscopy”. Journal of American Society of Nephrology 31(9): 2223-2224. Doi: https://doi.org/10.1681/ASN.2020050755. Enlace.
MINA, M.J. PARKER, R. LARREMORE, D.B. 2020. “Rethinking Covid-19 Test Sensitivity. A Strategy for Containment”. The New England Journal of Medicine 383: e120. Doi: 10.1056/NEJMp2025631. Enlace.
MINA, M.J. PETO T.E. et al. 2021. “Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19”. Lancet 396 (10283): 1425/1427. Doi: 10.1016/S0140-6736(21)00425-6. Enlace.
MONTAGNIER, L. AÏSSA, J. et al. 2009. “Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences”. Interdisciplinary Science 1(2): 81-90. Doi: 10.1007/s12539-009-0036-7. Enlace.
MUNAR, C. CASTELLANOS, J.E. RODRIGUEZ, M.H. 2019. “Antibody- dependent enhancement in the inmunopathogenesis of severe dengue, implications for the development and use of vaccines”. Acta Biológico Colombiana 24(3): 439-445. Doi: 10.15446/abc.v24n3.79410. Enlace.
NELL, T. MCGORIAN, I. HUDSON, N. 2020. “exploring inter-country coronavirus mortality”. Pandemics, Data & Analitics. Publicado online 09-07-2020. Enlace.
NOVEMBRE, F.J. SAUCIER, M. et al. 1997. “Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1”. Journal of Virology 71(5): 4086–4091. Doi: 10.1128/JVI.71.5.4086-4091.1997. Enlace.
OCHIAI, H. KUROKAWA, M. et al. 1992. “Infection enhancement of influenza a NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody.” Journal of Medical Virology 36(3): 217-221. Doi.org/10.1002/jmv.1890360312. Enlace.
OLIVA, A.M. 2020. “Ondas y salud. Una visión electromagnética de la vida”. Dossier Cv20, Cauac Editorial, Murcia, España.
OPOKA-WINIARSKA, V. GRYWALSKA, E. ROLINSKI, J. 2020. “Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?”. BMC Medicine 218:214. Doi: 10.1186/s12916-020-01682-y. Enlace.
ORBACH, H. AGMON-LEVIN, N. ZANDMAN-GODDARD, G. 2010. “Vaccines and autoimmune diseases of the adult”. Discovery Medicine 9(45): 90-97. PMID:20193633. Enlace.
PALL, M.L. 2013. “Electromagnetic fields act via activation of voltage gated calcium channels to produce beneficial or adverse effects”. Journal of Cellular and Molecular Medicine 17(8): 958-965. Doi: 10.1111/jcmm.12088. Enlace.
PAPADOPULOS-ELEOPULOS, E., TURNER, V.F. (Sin fecha) “Isolated facts about HIV – a reply”. Enlace.
PARK, W.B. KWON, N-J. et al. 2020. “Virus Isolation from the First Patient with SARS-CoV-2 in Korea”. Journal of Korean Medical Science 35(7): E84. Doi: 10.3346/jkms.2020.35.e84. Enlace.
PAYERAS I CIFRE, B. 2021. “5G, Asistencia Sanitaria y Teoría Ambiental”. Dossier Cv20, Cauac Editorial, Murcia, España. Enlace.
PEIRIS, J.S., CHU, C.M. et al. 2003. “Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.” The Lancet 361(9371): 1767-72. Doi: 10.1016/s0140-6736(03)13412-5. Enlace.
PLANKAR, M. JERMAN, I. KRAŠOVEC, R. 2011. “On the origin of cancer: Can we ignore coherence?” Progress in Biophysics and Molecular Biology 106(2): 380-390. Doi: 10.1016/j.pbiomolbio.2011.04.001. Enlace.
POLLACK, G. 2013. The Fourth Phase of Water. Ebner and Sons Publishers, Seattle, Washington, EEUU. Enlace.
POPP, F.A. 2003. “Properties of biophotons and their theoretical implications”. Indian Journal of Experimental Biology 41(05): 391-402. Doi: 123456789/17031/1. Enlace.
PRADHAN, P., PANDEY, A.K. et al. 2020. “Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and gag.” BioRXiv, Preprint. Doi: 10.1101/2020.01.30.927871. Enlace.
PRAY, I.W. FORD, L. et al. 2021. “Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses”. CDC, Morbidity and Mortality Weekly Report 69: 1642–47. Doi: 10.15585/mmwr.mm695152a3. Enlace.
RAMUNDO-ORLANDO, I. 2010. “Effects of millimeter waves radiation on cell membrane”. Journal of Infrared, Millimeter and Terahertz Waves 31: 1400. Doi: 10.1007/s10762-010-9731-z. Enlace.
RAUG, LW. SCHMIDT R. 1965.”Measles immunization with killed virus vaccine. Serum antibody titers and experience with exposure to measles epidemic.” American Journal of Diseases of Children 109: 232-7. Doi: 10.1001/archpedi.1965.02090020234007. Enlace.
RAUP, D.M. 1994. “The role of extinction in evolution”. Proceedings of the National Academy of Sciences 91(15): 6758-6763. Doi: 10.1073/pnas.91.15.6758. Enlace.
RICKE D.O. 2021 “Two different antibody-dependent enhancement (ADE) risks for SARS-CoV-2 antibodies”. Frontiers in Immunology 12: 640093. Doi: 10.3389/fimmu.2021.640093. Enlace.
ROBINSON, W.E. MONTEFIORI, D.C., MITCHELL, W.M. 1988. “Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.” The Lancet 331(8589): 790-794. Doi: 10.1016/s0140-6736(88)91657-1. Enlace.
ROSCH, P. J. 2009. “Bioelectromagnetic and subtle energy medicine”. Annals of the New York Academy of Sciences 1172(1): 297. Doi: 10.1111/j.1749-6632.2009.04535.x. Enlace.
RUBIK B. BROWN, R.R. 2021 “Evidence for a connection between COVID-19 and exposure to radiofrequency radiation from wireless telecommunications including microwaves and millimeter Waves. Artículo no publicado. Doi: 10.31219/osf.io/9p8qu. Enlace.
SALA, A. 2021. Magna Ciencia Vol. II. Cauac Editorial, Murcia, España. Enlace.
SANDÍN, M. 1995. Lamarck y los mensajeros: la función de los virus en la evolución. AKAL Publishers, Madrid, España. Enlace.
SANDÍN, M. 2010a. Pensando la evolución, pensando la vida. Cauac Editorial, Murcia, España. Enlace.
SANDÍN, M. 2010b. “Lamarck y la venganza del imperio”. Enlace.
SANDÍN, M. 2020. Trilogía del coronavirus. Cauac Editorial, Murcia, España. Enlace.
SAUTTO, G.A. KIRCHENBAUM, G.A. ROSS, T.M. 2018. “Towards a universal influenza vaccine: different approaches for one goal”. Virology Journal 15: 17. Doi: 10.1186/s12985-017-0918-y. Enlace.
SAWAYA, B.P. BRIGGS, J.P. SCHNERMANN, J. 1995. “Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties”. Journal of American Society of Neprhology 6(2): 154–164. Doi: 10.1681/ASN.V62154. Enlace.
SCOGLIO, S. 2020. The invented pandemic, the lack of virus isolation and the invalid covid-19 test. Enlace.
SEIFARTH, W. SKLADNY, H.et al. 1995. “Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences”. Journal of Virology 69(10): 6408-6416. Doi: 10.1128/JVI.69.10.6408-6416.1995. Enlace.
SHOENFELD, Y. AGMONĹEVIN, R. TOMLJENOVIC, L. 2015. Vaccines and Autimmunity. Wiley Blackwell, Oxford. Enlace.
SINOUSSI, F. MENDIOLA L. et al 1973. “Purification and partial differentiation of the particles of murine sarcoma virus (M. MSV) according to their sedimentation rates in sucrose density gradients”. Spectra 4: 237-243. Enlace.
SKALNY, A.V. TINKOV, A.A. et al. 2020. “Toxic metal exposure as a possible risk factor for covid-19 and other respiratory infectious diseases”. Food and Chemical Toxicology 146: 111809. Doi: 10.1016/j.fct.2020.111809. Enlace.
SPEECKAERT, M.M, SPEECKAERT, R. et al. 2005. “Vitamin D binding protein: a multifunctional protein of clinical importance.” Advances in Clinical Chemistry 63: 1-57. Doi: 10.1016/B978-0-12-800094-6.00001-7. Enlace.
SRIDHAR, S. LUEDTKE, A. et al. 2018. “Effect of dengue serostatus on dengue vaccine safety and efficacy.”New England Journal of Medicine 379 (4): 327-340 Doi: 10.1056/NEJMoa1800820. Enlace.
STEINER, R. 1921. Conferencia de Dornach, 13 de abril; GA313. Manuscrito en alemán. Enlace.
STEINER, R. 2012. On Epidemics: Spiritual Perspectives. Rudolf Steiner Press. Forest Row, Reino Unido. Enlace.
TOKEL-WALKER, C. 2021. “What we know about covid-19 reinfection so far”. British Medical Journal 372: n99. Doi: 10.1136/BMJ.n99. Enlace.
STRANSKY, G. VERNON, J. et al. 1993.“Virus-like particles in synovial fluids from patients with rheumatoid arthritis”. British Journal of Rheumatology, 32 (12): 1044-1048. Doi: 10.1093/rheumatology/32.12.1044. Enlace.
SUTTLE, C.A. 2005. “Viruses in the Sea”. Nature 437(7057): 356-361. Doi: 10.1038/nature04160. Enlace.
SZENT-GYÖRGYI, A. 1956. “Bioenergetics”. Science 124(3227): 873-875. Doi: 10.1126/science.124.3227.873. Enlace.
TAKADA, A., WATANABE, S. et al. 2001. “Infectivity enhancing antibodies to Ebola virus glycoprotein”. Journal of Virology 75: 2324-2330. Doi: 10.1128/jvi.75.5.2324-2330.2001. Enlace.
TAKKOUCHE, B. REGUEIRA, C. GESTAL-OTERO, J.J. 2001. “A cohort study of stress and the common cold”. Epidemiology 12(3): 345-349. Doi: 10.1097/00001648-200105000-00015. Enlace.
TAKKOUCHE, B. REGUEIRA-MÉNDEZ, C. et al. 2002. “Intake of vitamin C and zinc and risk of common cold: a cohort study”. Epidemiology 13(1): 38-44. Doi: 10.1097/00001648-200201000-00007. Enlace.
TAKKOUCHE, B.REGUEIRA-MÉNDEZ, C. et al. 2002. “Intake of wine, beer, and spirits and the risk of clinical common cold. American Journal of Epidemiology 155(9): 853-858. Doi: 10.1093/aje/155.9.853. Enlace.
TER-OVANESYAN, D. 2011. “Exosomes: The Little Vesicles that Could”. Boston Biotech Watch. Enlace.
THORÉN, F. RIISE, R.E. et al. 2012. “Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism”. Journal of Inmunology 188(4): 1668-1674. Doi: 10.4049/jimmunol.1102002. Enlace.
TILLACK, K. BREIDEN, P. et al. 2012. “T Lymphocyte Priming by Neutrophil Extracellular Traps Links Innate and Adaptive Immune Responses”. Journal of Inmunology 188(7): 3150-3159. Doi: 10.4049/jimmunol.1103414. Enlace.
TOPLIN 1973 “Tumor Virus Purification using Zonal Rotors”. Spectra 4: 225-235. Enlace.
TYRRELL, D.A. BYNOE, M. L. 1965. “Cultivation of a Novel Type of Common-cold Virus in Organ Cultures”. British Medical Journal 1: 1467-1470. Doi: 10.1136/bmj.1.5448.1467. Enlace.
VAN DER HOEK, L. PYRC, K. et al. 2004. “Identification of a new human coronavirus”. Nature Medicine 10(4): 368–373. Doi: 10.1038/nm1024. Enlace.
VAN DER HOEK, L. PYRC, K. BERKHOUT, B. 2006.“Human coronavirus NL63, a new respiratory virus”. FEMS Microbiology Review 30(5): 760–773. Doi: 10.1111/j.1574-6976.2006.00032.x. Enlace.
VAN DER POL, E. BÖING A.N. et al. 2012. “Classification, functions, and clinical relevance of extracellular vesicles”. Pharmacological reviews 64(3): 676-705. Doi: 10.1124/pr.112.005983. Enlace.
VAN ERP, E.A., LUYTJES, W. el al. 2019 “Fc-Mediated antibody effector functions during respiratory syncytial virus infection and disease.” Frontiers in Immunology 22;10:548. Doi: 10.3389/fimmu.2019.00548. Enlace.
VAN WIJK, R. 2001. “Bio-photons and bio-communication”. Journal of Scientific Exploration 15(2): 183-197. Enlace.
VERNON, G. 2020. “Of HERVs and Covid-19: Questions for the Future”. British Journal of General Practice. Enlace.
VILARREAL, A. 2020. “Las primeras autopsias de Covid-19 revelan un ‘thriller’ microbiológico en los pulmones”. El Confidencial, 25-10-2020.
VODYANOY, V. PUSTOVYY, O. et al. 2015. “Primo-vascular system as presented by Bong Han Kim”. Evidence-Based Complementary and Alternative Medicine. Doi: 10.1155/2015/361974. Enlace.
WADMAN, M. 2020. “Flawed interferon response spurs severe illness”. Science 369(6511): 1550-1551. Doi: 10.1126/science.369.6511.1550. Enlace.
WAN, Y. SHANG, J. et al. 2020. “Molecular mechanism for antibody-dependent enhancement of coronavirus entry.” Journal of Virology 14; 94(5): e02015-19. Doi: 10.1128/JVI.02015-19. Enlace.
WANG, S.F. TSENG, S.P. et al. 2014. “Antibody-dependent sars coronavirus infection is mediated by antibodies against spike proteins.” Biochemical and Biophysical Research Communications, 451 (2): 208-214. Doi: 10.1016/j.bbrc.2014.07.090. Enlace.
WANG-SHICK, R. 2017. “New emerging viruses”. Molecular Virology of Human Pathogenic Viruses. Academic Press Publishers. Cambridge, Massachusetts, EEUU. Doi: 10.1016/C2013-0-15172-0. Enlace.
WARING, M.J. 1965. “Complex formation between ethidium bromide and nucleic acids”. Journal of Molecular Biology. 13(1): 269–282. Doi:10.1016/S0022-2836(65)80096-1. Enlace.
WEHENKEL, C. 2020. “Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide” Peer journal, 8: e10112. Doi: 10.7717/peerj.10112. Enlace.
WEIL, P. LELOUP, JY. CREMA, R. 2017. Normose: A patologia da normalidade. Editora Vozes Limitada, São Paulo, Brasil. Enlace.
WILLEMSEN, A. ZWART, M.P. 2019. “On the stability of sequences inserted into viral genomes” Virus Evolution 5(2): vez045. Doi: 10.1093/ve/vez045. Enlace.
WITZANY, G. 2009. “Noncoding RNAs: Persistent Viral Agents as Modular Tools for Cellular Needs” Annals of the New York Academy of Sciences 1178: 244-267. Doi: 10.1111/j.1749-6632.2009.04989.x. Enlace.
WU, K.J. 2020. “There are more viruses than stars in the universe. Why do only some infect us?” National Geographic. Enlace.
WU, X. NETHERY R.C. et al. 2020. “Exposure to air pollution and COVID-19 mortality in the United States: A nationwide cross-sectional study”. Science Advances 6(45): eabd4049. Doi: 10.1126/sciadv.abd4049. Enlace.
YAMAMOTO, N. 2006. “Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1” AIDS Research and Human Retroviruses 22 (3): 262-271. Doi:10.1089/aid.2006.22.262. Enlace.
YAMAMOTO, N., URADE, M. 2005.“Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus” Microbes and Infection, 7 (4): 674-681. Doi: 10.1089/aid.2006.22.262. Enlace.
YAMAMOTO, N. HOMER, S. 1991. Vitamin D3 binding protein (group specific component) is a precursor for the macrophage-activating signal factor lisophosphatifilcoline-treated lymphocites”. Proceedings of the Natural Academy of Sciences 88(19): 8539-43. Doi: 10.1073/pnas.88.19.8539. Enlace.
YAO, H. SONG, Y. et al. “Molecular Architecture of the SARS-CoV-2” Virus Cell 183(3): 730–738.e13. Doi: 10.1016/j.cell.2020.09.018. Enlace.
YIP, M.S. LEUNG, H.L. 2016. “Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS”. Hong Kong Medical Journal, 22(3 Suppl 4):25-31. PMID: 27390007. Enlace.
YONGZHI, X. 2021. “COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue”. Emerging Microbes and Infections 10(1): 266-276. Doi: 10.1080/22221751.2021.1884503. Enlace.
YUANA, Y. KONING, R.I. et al. 2013. “Cryo-electron microscopy of extracellular vesicles in fresh plasma”. Journal of Extracell Vesicles 2: 10.3402. Doi: 10.3402/jev.vi0.21494. Enlace.
ZARAGOZA A. 2007. “El motor de la coevolución entre plantas e insectos: los virus”. Trabajo de grado sin publicar. Universidad Autónoma de Madrid, España. Enlace.
ZARAGOZA. A. 2020a. “El resfriado común, la sentencia a los virus y la mentira de la COVID-19”. Aliados del Virus. Enlace.
ZARAGOZA A. 2020b. “Sobre el origen de los virus y los positivos sanos”. Somosbacteriasyvirus.com. Enlace.
ZEICHHARDT H. KAMMEL M. 2020 Kommentar zum Extra Ringversuch Gruppe 340 Virusgenom-Nachweis. Instand e.V. Publishers, Düsseldorf, Alemania. Enlace.
ZHANG, Q. 2020. “Inborn errors of type I IFN immunity in patients with life-threatening COVID-19”. Science 370(6515): eabd4570. Doi: 10.1126/science.abd4570. Enlace.
ZHANG, T. BREITBART, M. et al. 2006. “RNA Viral Community in Human Feces: Prevalence of Plant Pathogenic Viruses”. PLoS Biology 4(1): e30109. Doi: 1.1371/journal.pbio.0040003. Enlace.
ZHOU, J.Y. ZHANG, D.Y. et al. 2004. Characterization of an Avian Infectious Bronchitis Virus Isolated in China from Chickens with Nephritis. Journal of veterinary medicine. B, Infectious diseases and veterinary public health, 51(4): 147–152. Doi: 10.1111/j.1439-0450.2004.00744.x. Enlace.
ZHU N, ZHANG D, et al. 2020 “A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382(8):727-733. Doi: 10.1056/NEJMoa2001017. Enlace.
ZIMMER, C. 2020. “The Coronavirus unveiled” New York Times. Enlace.
Fe de errores - Volúmen I, primera edición (julio de 2020)
Pág. 7 | *Título «El virus que nos tiene que hacer virar«. Debe poner a continuación «, por Karmelo Bizkarra». |
Pág. 10 | *Último párrafo, tercera línea: después de «Belén Doménech,» añadir «Beatriz Ramos, Eneko Lezaola,» |
Pág. 42 | *Línea 5: «a un 50 % de personas». Debe poner «a un 50% de personas». *Línea 7: «o solución extraída». Debe poner «o con solución extraída». |
Pág. 56 | *Segundo párrafo, línea 5: después de «vírico», el 2 debe ir como superíndice. *Tercer párrafo, línea 2: después de «verdadero positivo», el 3 debe ir como superíndice. |
Pág. 60 | *Tercer párrafo: «Sars-cov-1» y «Sars-cov-2» deben sustituirse por «SARS-CoV-1″ y SARS-CoV-2». *Quinto párrafo: «Sars-cov-2«, sustituir por «SARS-CoV-2«. *Sexto párrafo: Idem que en el quinto párrafo. |
Pág. 63 | *Primera linea: «Sars-cov-2». Debe poner «SARS-CoV-2». |
Pág. 79 | *Último párrafo, línea 5: «inconsistencia de resulatdos». Debe poner «inconsistencia de resultados». |
Pág. 98 | *Primer párrafo, linea 3: «severas y duraraderas». Debe poner «severas y duraderas. |
Pág. 125 | *Tercer párrafo, última linea: «(enlace 608)». Debe poner «(enlace 508)». |
Pág. 126 | *Título de sección: «La hematoglutanina«. Debe poner «La hematoglutinina«. |
Pág. 130 | *Penúltimo párrafo, tercera linea: «la subunidad de fusión S2». Debe poner «la subunidad S1 de unión al receptor». |
Pág. 158 | *Texto al pie del cuadro 3. Antepenúltima linea: «fecha de inicio de la regulación más estricta en espacios interiores». Debe poner «fecha de inicio de la regulación en espacios interiores». |
Pág. 163 | *Nota de pie de imagen de la Figura 8: «Correlación entre TMcov y factores demográficos». Debe poner «A: Correlación entre TMcov y factores demográficos». |
Pág. 171 | *Texto al pie de la Figura 13. Explicación del Grupo 2: «Contiene al segundo cuartil (25%) del rango de distribución de países por gasto sanitario». Debe poner «Contiene el rango entre el segundo y el tercer cuartil de la distribución del gasto sanitario anual por países». *Texto al pie de la Figura 13. Explicación del Grupo 3: «Contiene al tercer cuartil (25%) del rango de distribución de países por gasto sanitario». Debe poner «Contiene el rango entre el primer y el segundo cuartil de la distribución del gasto sanitario anual por países». |
Pág. 177 | *Última frase del último párrafo: «médicos italianos declaran públicamente ni más ni menos que ante el Congreso de los diputados que han estado matando a sus pacientes». Debe poner «el médico italiano Pasquale Mario Bacco declara públicamente ni más ni menos que ante el Congreso de los diputados que él y sus colegas han estado matando a sus pacientes al quemar sus pulmones con la ventilación profunda». |
Pág. 207 | *Nota al pie 2, segunda línea: «la prueba no es vá lida». Debe poner «la prueba no es válida». |
Pág. 248 | «HAMER, R.G.». Debe poner «HAMER, R.D.». |
Pág. 265 | *Presentación de Bartomeu Payeras: «… en el IEM de Mallorca durante ( ) años. En ( ) crea el Departamento de Microbiología…» Debe poner «…en el IEM de Mallorca durante 30 años. En 1974 crea el Departamento de Microbiología…» |